Monocytes from peripheral blood and synovial fluid of patients with definite and classic rheumatoid arthritis spontaneously produced significantly greater amounts of prostaglandin E2 (PGE2), leucotriene B4 (LTB4), and interleukin-l, (IL-10) than samples of peripheral blood from normal controls. Peripheral blood monocytes from patients with rheumatoid arthritis produced significantly greater amounts of PGE2 than control samples when stimulated with lipopolysaccharide. There were no significant differences in the spontaneous release of superoxide or N-acetyl-i-D-glucosaminidase by peripheral blood monocytes between patients and healthy controls. Both stimulated and unstimulated peripheral blood monocytes from patients with definite or classic rheumatoid arthritis produced significantly greater amounts of PGE2 than samples from normal controls. This was true, regardless of the stage of disease and the presence or absence of roentgenological joint abnormalities. Amounts of N-acetyl-P-Dglucosaminidase released by peripheral blood monocytes from patients correlated positively with the erythrocyte sedimentation rate (ESR) and negatively with duration of disease. Amounts of IL-1lB and N-acetyl-13-D-glucosaminidase released from the peripheral blood monocytes of patients who had had their disease for less than one year were significantly higher than those of normal controls. There were no significant correlations between the types of treatment and the amounts of PGE2, LTB4, IL-1l6 or N-acetyl-,3-D-glucosaminidase released by peripheral blood monocytes in patients with rheumatoid arthritis.
Rheumatoid arthritis affects peripheral joints, and the destruction of joint structures, demonstrable on x ray examination, is the most important feature for prognosis. The aetiology and pathogenesis of rheumatoid arthritis are poorly understood, but there are many indications that immune mechanisms may be involved. interleukin-l (IL-1). 1012 The best characterised product of monocyte-macrophages is IL-1. It has been shown that IL-l plays an important part in tissue damage by inducing a variety of functional changes of pathogenetic importance in other cells.47 1-15 Stimulation of monocytes also leads to the release of lysosomal enzymes and activation of enzymes which produce mediators of inflammation. These include membrane bound nicotinamide-adenine dinucleotide phosphate oxidase (NADPH oxidase), which generates 02, and a 5-lipo-oxygenase, which catalyses the production of leucotrienes (LTB4).
Lysosomal proteinases and 02 radicals are thought to be largely responsible for the resulting tissue injury found during an inflammatory reaction. Monocytes in rheumatoid arthritis have been shown to possess enhanced Fc receptor binding activity 6 and enhanced metabolic and secretory activity. '7 Monocytes in rheumatoid arthritis also produce increased amounts of PGE218 and IL-l. '9 20 The aim of this study was to determine whether the release of PGE2, LTB4, IL-1, 02
and N-acetyl-4-D-glucosaminidase, a lysosomal proteinase, from monocytes is a specific marker of the early stage of rheumatoid arthritis and to correlate these mediators with inflammatory variables in patients with rheumatoid arthritis. Serum rheumatoid factor was measured by laser nephelometry (Behring) using a rheumatoid arthritis test kit (Hoechst) (normal range below 13 IU/ml). Total haemolytic complement concentrations (CH50) were measured according to the method of Kent and Fife.25 C3 and C4 were measured by single radial immunodiffusion using commercial kits (Hoechst).
Methods

ISOLATION OF MONOCYTES
Twenty millilitres of venous blood treated with heparin were collected, diluted with an equal volume of phosphate buffered saline (PBS) (0-01 M phosphate, 0 138 M NaCl, pH 7 4), and the mononuclear cells were isolated by Ficoll-Hypaque density gradient centrifugation (Pharmacia Fine Chemicals). Synovial fluid was aspirated from the knee joints of patients with rheumatoid arthritis into polystyrene tubes containing sodium heparin, diluted 1/1 with PBS, and centrifuged at 200 g. Cells were resuspended in PBS, layered on Ficoll-Hypaque, and centrifuged. Cells at the resulting interface were aspirated, washed twice in PBS, and suspended at a concentration of 2 x 106/ml in RPMI 1640 medium, supplemented with 100 U/ml penicillin, 100 Zg/ml streptomycin, 0 25 ng/ml fungizone, 2 mmol/ml L-glutamine, and 10% heat inactivated fetal calf serum (FCS) (Gibco). These cells were then incubated in Petri dishes (Falcon, 3002) which had been coated with FCS and then incubated for one hour at 37°C in a 5% carbon dioxide incubator. Non-adherent cells were gently poured from the dishes and discarded. The dishes were rinsed with medium, and adherent cells were released into RPMI medium by mechanical agitation. The until use when they were assayed for PGE2, LTB4, N-acetyl-13-D-glucosaminidase, and IL-113. As a stimulating agent, heat aggregated human IgG was used. This was prepared by heating native IgG (Cohn Fraction II, Sigma, 10 mg/ml) at 37°C for 20 minutes, followed by centrifugation at 3000 rpm for 20 minutes to remove large aggregates. The final concentration of heat aggregated human IgG was 500 ptg/ml.
A competitive binding radioimmunoassay was used for PGE2 using a commercial kit (Amersham). Leucotriene B4 was also measured by radioimmunoassay using a commercial kit (Amersham).
N-acetyl-f3-D-glucosaminidase was measured as described previously.26 Briefly, 0-2 ml of sample, diluted 1/1 with 0-1 ml of 0-1 M citrate buffer (pH 4-5), was incubated in glass tubes with 3-6 mM paranitrophenyl-2-acetamido-2-deoxy-13-D-glucopyranoside (Sigma) as substrate for four hours at 37°C. The reaction was terminated with 0 3 ml of 1 M borate buffer (pH 9-8) and enzyme activity was determined colorimetrically at 405 nm as paranitrophenol was released from the substrate. Values were corrected for background levels in the medium. 02 generation by monocytes was measured as described previously.27 Monocytes (0-2 ml) suspended in HBSS were plated in 96-well plates (Falcon), and ferricytochrome c (horse heart, type III, Sigma) was added at the final concentration of 55 iimol/l. In control wells 02 dismutase (SOD, Sigma 3000 U/mg, 20 pg/ml) was added. Cells were then cultured for four hours at 37°C. After incubation supernatants were obtained, diluted in distilled water, and reduction of ferricytochrome c was measured by reading absorbance at 550 nm using a Beckman model 35 spectrophotometer. The amount of ferricytochrome c reduction inhibited by SOD was calculated as described previously.28 Rates of ferricytochrome c reduction were linear even at four hours.
IL-1,6 was measured by enzyme linked immunosorbent assay (ELISA) using a kit recently developed by Otsuka Pharmaceutical Co Ltd.29 Ninety six well-plates were coated overnight at room temperature with 0 1 ml of antihuman mouse IL-1,B monoclonal antibody30 diluted with PBS to a final concentration of 10 [tg/ml. Plates were then washed three times with PBS. To avoid non-specific adsorption, 0 4 ml of 1% bovine serum albumin (Sigma) was added to each well. Plates were kept at room temperature for four hours. After the blocking solution was removed each well was washed with 0-4 ml of PBS and 0-05% Tween 20. A solution of IL-1B containing 40 ng/ml of human recombinant IL-1,B was serially diluted with PBS and the dilutions used as standards.3' Samples or serially diluted standards (0-1 ml) were added to each well and incubated at 4°C overnight. Each well was washed three times with PBS after the samples or standards had been removed. Rabbit antihuman IL-1,6 polyclonal antibody (0-1 ml) was added to each well and incubated at room temperature for two hours. Wells were washed three times with PBS. Horseradish peroxidase-conjugated antirabbit IgG (0-1 ml) was added to each well.
After incubation for two hours at room temperature the wells were washed with PBS and 0-1 ml of substrate solution (0-02% hydrogen peroxide, 1 mg/ml o-phenylenediamine dihydrochloride in 01 M phosphate buffer, pH 5-5) was added. Plates were kept at room temperature for 10-15 minutes and the reaction was stopped by adding 01 ml of 1 N H2SO4 solution. Absorbance was measured at 492 nm using an ELISA reader (Dainippon-Sei-yaku Co Ltd). This ELISA assay detects 15-6-500 pg/ml of IL-1,B.
Levels (table 2) .
The amounts ofN-acetyl-,3-D-glucosaminidase released by peripheral blood monocytes from patients with rheumatoid arthritis correlated positively with ESR and negatively with duration of disease. The amount of N-acetyl-P-D-glucosaminidase released, however, did not correlate with activity index (table 3) . There were no significant correlations between the amounts of PGE2, LTB4, 02 or IL-1,6 and ESR, activity index, or duration of disease. There were no differences in the amounts of mediators released by peripheral blood monocytes in rheumatoid arthritis in the presence or absence of vasculitis (data not shown). When patients with rheumatoid arthritis were classified according to disease duration of less or more than one year and the amounts of mediators released by unstimulated peripheral blood monocytes were compared with those of healthy controls, the amounts of IL-l and N-acetyl-,3-D-glucosaminidase produced were significantly higher in patients with rheumatoid arthritis with disease duration less than one year. On the other hand, the production of PGE2 and LTB4 was not increased in patients with rheumatoid arthritis with disease duration of less than one year, but was significantly increased in patients with rheumatoid arthritis with disease duration of more than one year (table 4). show that PGE2 production is increased both at early and late stages of rheumatoid arthritis. In an animal model of arthritis in rats it was shown that induction and progression of arthritis was associated with both systemic (splenic, peritoneal) and local (synovial) macrophage activation, including enhanced production of PGE2 and IL-1 and increased Ia antigen expression.33
Production of another product of arachidonic acid, LTB4, is mediated by 5-lipo-oxygenase. Leucotriene B4 has potent chemotactic and degranulating actions, produces vascular permeability, and is reported to have a pro-inflammatory role in the arthritic joint.34 Our data indicate that peripheral blood monocytes in rheumatoid arthritis produce increased amounts of LTB4, but synovial fluid monocytes do not.
It has been shown that peripheral blood monocytes in rheumatoid arthritis release significantly greater amounts of IL-1 than normal peripheral blood monocytes, both stimulated and unstimulated, and that IL-1 generation by peripheral blood monocytes in rheumatoid arthritis is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis.20 Our data showed that IL-1 production was increased in an early stage of rheumatoid arthritis, but did not correlate with disease activity. The amounts of mediators released by unstimulated peripheral blood monocytes in rheumatoid arthritis were compared in patients with disease duration of less than one year and those with disease duration of more than one year. The data presented imply that the production of IL-1 B and N-acetyl-f3-Dglucosaminidase, but not PGE2 and LTB4, by unstimulated peripheral blood monocytes in rheumatoid arthritis is activated relatively early in rheumatoid arthritis and that in the chronic stage of the disease PGE2 and LTB4 production is activated but not that of IL-1l6 and N-acetyl-P3-D-glucosaminidase. Synovial 
